Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  Type 2 DiabetesPsychiatryIssue 681

Association between Smoking and Depression in Type 2 Patients

Smoking and depression are strongly associated in patients with type 2 diabetes....

Advertisement

The study population for the trial included a total of 1,868 adults with type 2 diabetes. Smoking was assessed in the study with five different categories which included: never, former, light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day). Depression was assessed and categorized in the study using a Patient Health Questionnaire. Depression was classified in a binary fashion in this study and patients were recorded as either having no major depression or major depression syndrome. To make sense of the relationship between individual's smoking activity and the presence of depression a statistical analysis using a logistic regression was used, while controlling for other demographic and health-related variables.

After the procedures of the study were carried out, the results showed that major depression was indeed associated with an augmented likelihood of being a smoker in any of the categories (light (≤10 cigarettes a day) and moderate/heavy (11+ cigarettes a day)). Depression; however, was also increased in the patients having 2 or more diabetes complications, moderate-severe disability or having 2 or more other chronic illnesses. In the fully adjusted study model, having major depression was associated with an increased likelihood of being a moderate or heavy smoker (odds ratio = 2.62, 95% confidence interval = 1.43–4.81). The statistical analysis from the study also showed that the association between a light smoker and major depression was not significant when adjusting for confounding variables.

Researchers concluded that smoking and depression are strongly associated in patients with type 2 diabetes. The association between smoking and the presence of major depression syndrome was strongest for diabetic patients classified as either moderate or heavy smokers. These findings potentially mean that depression may be a significant consideration when targeting clients with diabetes who continue to smoke and optimal mental health may not be obtainable until smoking cessation is achieved.

Matthew Clyde, Geneviève Smith, Norbert Gariépy, et al. Canadian Journal of Diabetes. Association between Smoking and Depression in a Canadian Community-Based Sample with Type 2 Diabetes. Vol. 37, Issue 3, June 4, 2013 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 June, 2013 and appeared in  Type 2 DiabetesPsychiatryIssue 681

Past five issues: Diabetes Clinical Mastery Series Issue 251 | Issue 791 | Diabetes Clinical Mastery Series Issue 250 | GLP-1 Special Editions July 2015 | Issue 790 |

2015 Most Popular Articles:

Self-Monitoring of Blood Glucose: The Patient's Perspective
Posted July 10, 2015
Diet That Mimics Fasting Appears to Slow Aging
Posted July 03, 2015
The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Weight Reduction
Posted July 10, 2015
Vitamin D3 Supplementation and Weight Loss Prevent Cancer in Older Women
Posted July 10, 2015
Important Advances in Type 1 Diabetes Research
Posted June 25, 2015
Evaluation of Cellphone Application that Records Readings from Glucometer
Posted July 10, 2015
Can the Insulin Patch Become a Reality?
Posted July 03, 2015
New Evidence Suggests Pioglitazone Reduces Dementia Risk 42%
Posted July 03, 2015
Metformin May Increase Mortality in Advanced CKD among Type 2 Patients
Posted July 10, 2015
Liraglutide Reducing Postprandial Hyperglycemia Using Closed Loop System
Posted June 25, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Would you be interested in a urine test strip product that measures microalbumin and creatinine levels to determine kidney failure risk in your patients?

CME/CE of the Week
Jeffrey M. Robbins, DPM

Category: General Diabetes
Credits: .5